← Back to Search

Dietary Supplement

Fiber Inulin for Chronic Obstructive Pulmonary Disease

N/A
Waitlist Available
Led By Marielle Engelen
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1, 2, 4, and 5

Summary

This trial is testing inulin, a type of dietary fiber, in patients with COPD. The goal is to see if fiber can help improve their condition by being broken down into substances that reduce inflammation and support the immune system. Inulin has been studied for its potential benefits in managing type 2 diabetes mellitus, including improving glycemic control and antioxidant status.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Aging

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intestinal microbiota composition by stool sample collection using Shallow Shotgun Sequencing
Whole body short-chain fatty acid production rates by plasma samples
Secondary study objectives
3-day diet diary
6 minute walk test distance
Attention and executive functions measured by Stroop Color-Word Test (SCWT)
+19 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Healthy Young ParticipantsExperimental Treatment2 Interventions
healthy young subjects with age 18-30 years old
Group II: Healthy ParticipantsExperimental Treatment2 Interventions
healthy control subjects
Group III: Chronic Obstructive Pulmonary Disease patientsExperimental Treatment2 Interventions
Established diagnosis of Chronic Obstructive Pulmonary Disease

Find a Location

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
147 Previous Clinical Trials
23,713 Total Patients Enrolled
Marielle EngelenPrincipal InvestigatorTexas A&M University - CTRAL
4 Previous Clinical Trials
234 Total Patients Enrolled

Media Library

Inulin (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04459156 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Chronic Obstructive Pulmonary Disease patients, Healthy Participants, Healthy Young Participants
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Inulin Highlights & Side Effects. Trial Name: NCT04459156 — N/A
Inulin (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04459156 — N/A
~28 spots leftby Nov 2025